Breaking
Breathwork Protocols

Mayo Clinic maps pulvinar to refine epilepsy stimulation

By Sebastian Wren 3 min read
Mayo Clinic maps pulvinar to refine epilepsy stimulation - pulvinar epilepsy
The findings back the Mayo Clinic’s BIONIC initiative, which unites clinicians, scientists and engineers to develop personalized neuromodulation therapies.

Scientists at Mayo Clinic have created a detailed network map of the pulvinar, a brain region, to enhance the accuracy of electrical stimulation treatments for individuals suffering from drug-resistant epilepsy. Published in the Journal of Neuroscience, these discoveries may allow doctors to pinpoint optimal electrode locations and design customized therapeutic approaches.

The pulvinar sits within the thalamus, a central brain structure responsible for integrating sensory inputs and supporting cognitive functions like vision, memory, and attention. While its therapeutic potential for epilepsy has been recognized, its deep-brain location has historically hindered full study of its neural connections.

Study Approach

For their analysis, the research team examined data from 30 patients with drug-resistant epilepsy who had received temporary electrode implants as part of standard medical evaluations. By delivering controlled electrical pulses to various pulvinar zones, they recorded the brain’s responses, revealing how distinct areas interact with other neural networks. Their results demonstrated that the pulvinar comprises specialized subregions, each linked to unique brain circuits rather than operating as a homogeneous unit.

Clinical Foundations and Industry Implications

The study expands on observations made while treating drug-resistant epilepsy. Researchers had expected stimulation of different pulvinar sites to engage similar networks, but they found varied responses. Some patients showed activity in visual processing regions, while others did not.

The findings back the Mayo Clinic’s BIONIC initiative, which unites clinicians, scientists and engineers to develop personalized neuromodulation therapies.

Treatment Advancements

Even minor spatial differences, just 3 millimeters apart, could correspond to connections with entirely separate neural pathways, according to Dora Hermes Miller, Ph.D., a biomedical engineer at Mayo Clinic and lead investigator. The study’s complexity far surpassed initial projections regarding the pulvinar’s role in epilepsy management.

These precise maps may now assist neurologists in optimizing deep brain stimulation (DBS) procedures, which use electrical signals to modulate abnormal brain activity. Accurate electrode placement is critical, as adjacent regions may trigger different neural responses and lead to varied therapeutic outcomes.

Nick Gregg, M.D., a Mayo Clinic neurologist and study co-author, noted that clinicians are already leveraging these maps to guide personalized pulvinar stimulation in epilepsy patients. Ongoing research is exploring how electrode positioning influences long-term treatment effectiveness.

With epilepsy impacting over 50 million people globally and roughly one-third of cases remaining uncontrolled by medications, neuromodulation presents a viable alternative for seizure management.

Gregory Worrell, M.D., Ph.D., another Mayo Clinic neurologist involved in the study, explained that the findings establish a foundation for adapting neuromodulation to the specific neural networks driving each patient’s epilepsy. Current efforts focus on determining which pulvinar subregions to target and which stimulation frequencies could maximize seizure control while reducing adverse effects.

Sebastian Wren

Leave a Reply

Your email address will not be published. Required fields are marked *